Pfizer, which developed the vaccine with its partner BioNTech, said the companies planned to apply to the Food and Drug Administration for emergency authorization "within days," raising hopes that a working vaccine could soon become a reality
A custodian walks across the glass bridge way at the Pfizer building in Cambridge, MA on Nov. 9, 2020. . Photo by David L. Ryan/The Boston Globe via Getty Images​
©2019 New York Times News Service